INS and diabetes mellitus: Among the treatment modalities for DM, diabetic patients receiving insulin therapy showed the highest risk of OHCA (aOR (95% CI): 6.63 (3.04–14.44)), whereas diabetic patients receiving oral hypoglycemic agents showed the lowest risk (aOR (95% CI): 1.47 (1.08–2.01)) compared to patients without diabetes.